Outcome signature genes in breast cancer: Is there a unique set?

Bioinformatics

Volumn 21, Issue 2, 2005, Pages 171-178

  Ein Dor, Liat ^a   Kela, Itai ^a   Getz, Gad ^a   Givol, David ^a   Domany, Eytan ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN;

ARTICLE; BREAST CANCER; CANCER GENETICS; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SIZE; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MASTECTOMY; METASTASIS POTENTIAL; OUTCOMES RESEARCH; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MICROARRAY; SENSITIVITY ANALYSIS;

EID: 13444282534     PISSN: 13674803     EISSN: 13674811     Source Type: Journal    
DOI: 10.1093/bioinformatics/bth469     Document Type: Article

References (32)

1. Bair,E. and Tibshirani,R. (2004) Semi-supervised methods to predict patient survival from gene expression data. PLoS Biol., 2, E108.
2. Beer,D.G., Kardia,S.L., Huang,C.C., Giordano,T.J., Levin,A.M., Misek,D.E., Lin,L., Chen,G., Gharib,T.G., Thomas,D.G. et al. (2002) Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat. Med., 8, 816-824.
3. Benjamini,Y. and Hochberg,Y. (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. Roy. Stat. Soc. B, 57, 289-300.
4. Bertucci,F., Houlgatte,R., Benziane,A., Granjeaud,S., Adelaide,J., Tagett,R., Loriod,B., Jacquemier,J., Viens,P., Jordan,B., Birnbaum,D. and Nguyen,C. (2000) Gene expression profiling of primary breast carcinomas using arrays of candidate genes. Hum. Mol. Genet. 9, 2981-2991.
5. Boon,K., Edwards,J.B., Siu,I.M., Olschner,D., Eberhart,C.G., Marra,M.A., Strausberg,R.L. and Riggins,G.J. (2003) Comparison of medulloblastoma and normal neural transcriptomes identifies a restricted set of activated genes. Oncogene, 22, 7687-7694.
6. Byron,S.A. and Yee,D. (2003) Potential therapeutic strategies to interrupt insulin-like growth factor signaling in breast cancer. Semin. Oncol., 30, 125-132.
7. Ciavarra,R.P., Brown,R.R., Holterman,D.A., Garrett,M., Glass,W.F.,II, Wright,G.L.Jr, Schellhammer,P.F. and Somers,K.D. (2003) Impact of the tumor microenvironment on host infiltrating cells and the efficacy of flt3-ligand combination immunotherapy evaluated in a treatment model of mouse prostate cancer. Cancer Immunol. Immunother. 52, 535-545.
8. Gruvberger,S.K., Ringner,M., Eden,P., Borg,A., Ferno,M., Peterson,C. and Meltzer,P.S. (2003) Expression profiling to predict outcome in breast cancer: the influence of sample selection. Breast Cancer Res., 5, 23-26.
9. Guerin,M., Sheng,Z.M., Andrieu,N. and Riou,G. (1990) Strong association between c-myb and oestrogen-receptor expression in human breast cancer. Oncogene, 5, 131-135.
10. Hromas,R., Broxmeyer,H.E., Kim,C., Nakshatri,H., Christopherson,K.,II, Azam,M. and Hou,Y.H. (1999) Cloning of BRAK, a novel divergent CXC chemokine preferentially expressed in normal versus malignant cells. Biochem. Biophys. Res. Commun., 255, 703-706.
11. Hughes,T.R., Mao,M., Jones,A.R., Burchard,J., Marton,M.J., Shannon,K.W., Lefkowitz,S.M., Ziman,M., Schelter,J.M., Meyer,M.R. et al. (2001) Expression profiling using microarrays fabricated by an ink-jet oligonucleotide synthesizer. Nat. Biotechnol., 19, 342-347.
12. Khan,J., Wei,J.S., Ringner,M., Saal,L.H., Ladanyi,M., Westermann,F., Berthold,F., Schwab,M., Antonescu,C.R., Peterson,C. and Meltzer,P.S. (2001) Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nat. Med., 7, 673-679.
13. Li,Y.M., Wen,Y., Zhou,B.P., Kuo.H.P., Ding,Q. and Hung,M.C. (2003) Enhancement of Bik antitumor effect by Bik mutants. Cancer Res. 63, 7630-7633.
14. Lossos,I.S., Czerwinski,D.K., Alizadeh,A.A., Wechser,M.A., Tibshirani,R., Botstein,D. and Levy,R. (2004) Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. N. Engl. J. Med., 350, 1828-1837.
15. Lotem,J., Gal,H., Kama,R., Amariglio,N., Rechavi,G., Domany,E., Sachs,L. and Givol,D. (2003) Inhibition of p53-induced apoptosis without affecting expression of p53-regulated genes. Proc. Natl Acad. Sci. USA, 100, 6718-6723.
16. Miklos,G.L. and Maleszka,R. (2004) Microarray reality checks in the context of a complex disease. Nat. Biotechnol., 22, 615-621.
17. Nguyen,D.V. and Rocke,D.M. (2002) Partial least squares proportional hazard regression for application to DNA microarray survival data. Bioinformatics, 18, 1625-1632.
18. Nilsson,I. and Hoffmann,I. (2000) Cell cycle regulation by the Cdc25 phosphatase family. Prog. Cell Cycle Res., 4, 107-114.
19. Ramaswamy,S., Ross,K.N., Lander,E.S. and Golub,T.R. (2003) A molecular signature of metastasis in primary solid tumors. Nat. Genet. 33, 49-54.
20. Rosenwald,A., Wright,G., Chan,W.C., Connors,J.M., Campo,E., Fisher,R.I., Gascoyne,R.D., Muller-Hermelink,H.K., Smeland,E.B., Giltnane,J.M. et al. (2002) The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N. Engl. J. Med., 346, 1937-1947.
21. Sakamuro,D., Elliott,K.J., Wechsler-Reya,R. and Prendergast,G.C. (1996) BIN1 is a novel MYC-interacting protein with features of a tumour suppressor. Nat. Genet., 14, 69-77.
22. Singhal,S., Amin,K.M., Kruklitis,R., DeLong,P., Friscia.M.E., Litzky,L.A., Putt,M.E., Kaiser,L.R. and Albelda,S.M. (2003) Alterations in cell cycle genes in early stage lung adenocarcinoma identified by expression profiling. Cancer Biol. Ther., 2, 291-298.
23. Sorlie,T., Perou,C.M., Tibshirani,R., Aas,T., Geisler,S., Johnsen,H., Hastie,T., Eisen,M.B., van de Rijn,M., Jeffrey,S.S. et al. (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl Acad. Sci. USA, 98, 10869-10874.
24. Sorlie,T., Tibshirani,R., Parker,J., Hastie,T., Marron,J.S., Nobel,A., Deng,S., Johnsen,H., Pesich,R., Geisler,S. et al. (2003) Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc. Natl Acad. Sci. USA, 100, 8418-8423.
25. Tibshirani,B.E.a.R.J. (ed.) (1993) An Introduction to the Bootstrap. Chapman and Hall, NY.
26. Urbanowicz-Kachnowicz,I., Baghdassarian,N., Nakache,C., Gracia,D., Mekki,Y, Bryon,P.A. and Ffrench,M. (1999) ckshs expression is linked to cell proliferation in normal and malignant human lymphoid cells. Int. J. Cancer, 82, 98-104.
27. van de Vijver,M.J., He,Y.D., van't Veer,L.J., Dai,H., Hart.A.A., Voskuil,D.W., Schreiber,G.J., Peterse,J.L., Roberts,C., Marton,M.J. et al. (2002) A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med., 347 1999-2009.
28. van't Veer,L.J., Dai,H., van de Vijver,M.J., He,Y.D., Hart,A.A., Mao,M., Peterse,H.L., van der Kooy,K., Marton,M.J., Witteveen,A.T. et al. (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature, 415, 530-536.
29. Varambally,S., Dhanasekaran,S.M., Zhou,M., Barrette,T.R., Kumar-Sinha,C., Sanda,M.G., Ghosh,D., Pienta,K.J., Sewalt,R.G., Otte,A.P., Rubin,M.A. and Chinnaiyan,A.M. (2002) The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature, 419, 624-629.
30. West,M., Blanchette,C., Dressman,H., Huang,E., Ishida,S., Spang,R., Zuzan,H., Olson,J.A.,Jr, Marks,J.R. and Nevins,J.R. (2001) Predicting the clinical status of human breast cancer by using gene expression profiles. Proc. Natl Acad. Sci. USA, 98, 11462-11467.
31. Winters,Z.E., Hunt,N.C., Bradburn,M.J., Royds,J.A., Turley,H., Harris,A.L. and Norbury,C.J. (2001) Subcellular localisation of cyclin B, Cdc2 and p21(WAF1/CIP1) in breast cancer. association with prognosis. Eur. J. Cancer, 37, 2405-2412.
32. Zhou,R., Diehl,D., Hoeflich,A., Lahm,H. and Wolf,E. (2003) IGF-binding protein-4: biochemical characteristics and functional consequences. J. Endocrinol., 178, 177-193.